THURMAN RANDY H
SEC insider (Form 3/4/5 filer). CIK 0001204059. Director at Outlook Therapeutics, Inc. (OTLK). 4 reported Form 4/5 transactions since Sep 2024; latest on May 26, 2026. Located in ISELIN, NJ.
Companies THURMAN RANDY H has filed insider reports for
- Outlook Therapeutics, Inc. (OTLK): Director
THURMAN RANDY H
CIK: 0001204059
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Outlook Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 26, 2026OTLK
Outlook Therapeutics, Inc.
PurchaseDirect5K shares at avg. $0.43$2K - Oct 1, 2025OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
286.7K shares- - Oct 1, 2024OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
56.6K shares- - Oct 1, 2024OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
89.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 26, 2026 | OTLK Outlook Therapeutics, Inc. | Purchase | 5,000 | $0.43 | $2,145 | Direct |
| Oct 1, 2025 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 286,734 | - | - | Direct |
| Oct 1, 2024 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 56,636 | - | - | Direct |
| Oct 1, 2024 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 89,549 | - | - | Direct |
1-4 of 4 transactions